Spatial immune atlas of breast cancer brain metastasis reveals CD163<sup>+</sup> macrophage reprogramming associated with immune escape.
Overview
- Department of Breast Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
- Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Zhujiang Hospital, Guangzhou, Guangdong, China
- Chinese Institutes for Medical Research, Beijing, China
- Department of Breast Cancer, Cancer Centre, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Abstract
Background: Brain metastases (BrM) remain a major cause of mortality in breast cancer (BC), yet the spatial organization and molecular circuitry of the metastatic immune microenvironment are poorly defined.
Methods: To address this gap, we integrated high-plex imaging mass cytometry (IMC) performed on human primary breast tumors (n=
Results: IMC resolved nine major cell classes and diverse epithelial, myeloid, and T-cell subtypes, and revealed a striking shift in macrophage polarization: CD163−CD11b− macrophages were markedly depleted in brain metastases, whereas CD163+ subsets persisted. Spatial analysis demonstrated the loss of the immune-permissive CN1 neighborhood in brain metastases, which is enriched in memory T cells, B cells, and dendritic cells, and the expansion of the immunosuppressive CN9 niche in brain metastases, containing CD163+ macrophages, invasion-like epithelial cells, and exhausted T cells. ScRNA-seq integration corroborated these findings by refining the annotation of major immune and stromal lineages and confirming CD163 expression patterns across macrophage subsets. ST deconvolution further reproduced these CN1-like and CN9-like domains in situ, validating their anatomical organization across BC and BrM. Ligand-receptor inference highlighted specific inhibitory pathways—including programmed cell death protein 1/
Conclusions: Together, these findings show a shift from permissive to suppressive immune niches, accompanied by pronounced macrophage reprogramming, as central features of BC adaptation to the brain. This spatially resolved framework provides mechanistic insight into the poor responsiveness of brain metastases to current immunotherapies and identifies defined inhibitory ligand-receptor axes as actionable targets for combination immunotherapy.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE225600, at NCBI GEO; found in the text, “Public single-cell RNA-sequencing integration”
- zenodo:14247036, at Zenodo; found in the text, “Spatial transcriptomics”
Data availability statement
Data are available upon reasonable request.
Reproduced under the paper's license (CC BY-NC), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 4 keywords, 11 MeSH terms, 5 funders, 53 references.
Cite
This paper
Zhu, J., Ye, J., Ma, Y., Lin, Z., Wen, Y., Sheng, J., & Yang, M. (2026). Spatial immune atlas of breast cancer brain metastasis reveals CD163&
BibTeX
@article{zhu2026spatial,
author = {Zhu, Jiale and Ye, Junjie and Ma, Yulin and Lin, Zhirong and Wen, Yupeng and Sheng, Jianpeng and Yang, Mei},
title = {{Spatial immune atlas of breast cancer brain metastasis reveals CD163\&
journal = {Journal for immunotherapy of cancer},
year = {2026},
month = jun,
volume = {14},
number = {6},
pages = {e014421},
publisher = {BMJ Publishing Group},
issn = {2051-1426},
doi = {10.1136/
url = {https://
pmid = {42342408},
pmcid = {PMC13295879}
}
RIS
TY - JOUR
AU - Zhu, Jiale
AU - Ye, Junjie
AU - Ma, Yulin
AU - Lin, Zhirong
AU - Wen, Yupeng
AU - Sheng, Jianpeng
AU - Yang, Mei
TI - Spatial immune atlas of breast cancer brain metastasis reveals CD163&
T2 - Journal for immunotherapy of cancer
J2 - J Immunother Cancer
PY - 2026
DA - 2026/
VL - 14
IS - 6
SP - e014421
SN - 2051-1426
PB - BMJ Publishing Group
DO - 10.1136/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1136/
"type": "article-journal",
"title": "Spatial immune atlas of breast cancer brain metastasis reveals CD163&
"container-title": "Journal for immunotherapy of cancer",
"author": [
{
"family": "Zhu",
"given": "Jiale"
},
{
"family": "Ye",
"given": "Junjie"
},
{
"family": "Ma",
"given": "Yulin"
},
{
"family": "Lin",
"given": "Zhirong"
},
{
"family": "Wen",
"given": "Yupeng"
},
{
"family": "Sheng",
"given": "Jianpeng"
},
{
"family": "Yang",
"given": "Mei"
}
],
"container-title-short":
"volume": "14",
"issue": "6",
"page": "e014421",
"DOI": "10.1136/
"PMID": "42342408",
"PMCID": "PMC13295879",
"ISSN": "2051-1426",
"publisher": "BMJ Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
24
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.xcrm.2026.102766 [code]
- A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.Journal: Cell reports. MedicineIn common: genetics / omics, other condition, 7 references
- [2] doi:10.1016/j.isci.2026.116517 [code]
- Spatially resolved transcriptomics in human brain metastases identifies macrophage-tumor interactions associated with survival.Journal: iScienceIn common: genetics / omics, other condition, 4 references
- [3] doi:10.1172/jci.insight.199498
- Distinct immune landscapes characterize highly versus minimally invasive brain metastases.Journal: JCI insightIn common: genetics / omics, other condition, 4 references
- [4] doi:10.1038/s42003-026-10259-z [code]
- Spatial transcriptomic profiling of developing mouse hearts reveals a spatially patterned signaling environment.Journal: Communications biologyIn common: genetics / omics, 4 references
- [5] doi:10.3389/fimmu.2026.1866830
- Heterogeneity of immune checkpoint inhibitor-related inflammatory central nervous system adverse event reporting signals in primary and metastatic brain tumors: a pharmacovigilance study with single-cell and spatial transcriptomic contextualization.Journal: Frontiers in immunologyIn common: genetics / omics, other condition, 3 references
- [6] doi:10.1016/j.cpblue.2026.100072 [code]
- NodoMap: A single-cell and spatial transcriptomic atlas of the mouse nodose ganglion.Journal: Cell press blueIn common: genetics / omics, 4 references
- [7] doi:10.1038/s41420-026-03084-0
- Brain metastases exhibit distinct spatial patterns of resident and infiltrating macrophages.Journal: Cell death discoveryIn common: other condition, 3 references
- [8] doi:10.1038/s41467-026-70715-6
- Identification of altered immune landscape at single-cell resolution in NSCLC brain metastasis and its association with poor immune checkpoint inhibitor responses.Journal: Nature communicationsIn common: other condition, 3 references
- [9] doi:10.1186/s12974-026-03964-3
- Circulating immune profiling reveals impaired monocyte states and trajectories driving immunosuppression in glioblastoma.Journal: Journal of neuroinflammationIn common: genetics / omics, other condition, 3 references
- [10] doi:10.1016/j.isci.2026.117206 [code]
- ReliST: A model-agnostic risk layer for spatial transcriptomics deconvolution.Journal: iScienceIn common: genetics / omics, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
